Topic
SpaceX Research
Current institutional research highlights a market environment that prioritizes private equity and large-scale technological infrastructure, both of which are central to the SpaceX narrative. While Goldman Sachs reports aggressive selling within the Industrials sector, there is a persistent institutional appetite for private markets as diversifiers that offer higher returns and lower volatility than traditional public indices. This focus on private assets is increasingly relevant as BlackRock emphasizes a 'speed and scarcity' theme, particularly regarding the projected $1 trillion annual AI infrastructure buildout. Despite potential headwinds from hawkish Federal Reserve policies and high institutional leverage reaching five-year peaks, there remains a tactical preference for U.S. equities and technology beneficiaries. Additionally, the development of liquid private equity investment vehicles is bridging the gap for retail access to historically illiquid segments of the market. Consequently, the research suggests that while the broader industrial sector faces selling pressure, capital continues to flow toward high-growth, private-market leaders that define the next generation of technological expansion.
4165 reports available
All reports
Page 169 of 174
Sentiment Buoyed by Hopes of a US-Iran Deal
Crédit Agricole CIB · May 11, 2026
Trust in AI
J.P. Morgan · May 11, 2026
MetaX GPU Ramp Up and 1Q26 Earnings Update
Goldman Sachs · May 11, 2026
Jahez International 1Q26 Earnings Update
Goldman Sachs · May 11, 2026
Top Ten Questions Answered
UBS · May 11, 2026
How Income Investors Can Tackle Higher Inflation
UBS · May 11, 2026
House View Daily Asia
UBS · May 11, 2026
Metcash Preliminary FY26 Conference Call Key Points
Goldman Sachs · May 11, 2026
Upwork Q1 2026 Review
Goldman Sachs · May 11, 2026
GS European Express: Big Oils, Sponsor Activity, and Capital Goods Update
Goldman Sachs · May 11, 2026
Utilities Daily: Elia Downgrade and Veolia Q1 Update
Goldman Sachs · May 11, 2026
Assessing the Potential Impact of New Hospital in Amaravati Market
Goldman Sachs · May 11, 2026
CSL First Take FY26 Trading Downgrade
Goldman Sachs · May 11, 2026
Capacity Expansion Plans and Direct Customer Investment
Goldman Sachs · May 11, 2026
Elia Group Structurally Compelling
Goldman Sachs · May 11, 2026
China Hospital Equipment Bidding Update April 2026
Goldman Sachs · May 11, 2026
Europe Capital Goods 1Q26 Heatmap and CNH Update
Goldman Sachs · May 11, 2026
Dividend Screener
UBS · May 11, 2026
Fidelity National Information Services 1Q26 Takeaways
Goldman Sachs · May 11, 2026
BioAge Labs R&D Day and NLRP3 Asset Analysis
Goldman Sachs · May 11, 2026
Markets Today
Bank of New Zealand (BNZ) · May 10, 2026
Latam Views: Cruising Not Cracking
Goldman Sachs · May 10, 2026
Bertschis Chart Outlook
FinChartOutlook GmbH · May 10, 2026
The Tech Trade Rolls On
J.P. Morgan · May 10, 2026